Leerink Swann maintains an 'Outperform' on Corcept Therapeutics (CORT); Korlym Approved. Launch To Start On May 1
Go back to Leerink Swann maintains an 'Outperform' on Corcept Therapeutics (CORT); Korlym Approved. Launch To Start On May 1| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 118.10 +0.93 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $117.17 | 52 Week High | $10.00 | |||
| Open | $116.60 | 52 Week Low | $3.22 | |||
| Day High | $119.95 | P/E | N/A | |||
| Day Low | $116.60 | EPS | $-0.46 | |||
| Volume | 781,018 | |||||
